In contrast, overexpression of NM23-H1 in a metastatic breast cancer cell line [61,63,64] or injection of NM23-H1-conjugated nanoparticles into mouse xenographs results in a loss of invasiveness [65]. The gene discussed is NME1; the disease is breast carcinoma.